↓ Skip to main content

Cochrane Database of Systematic Reviews

Clonazepam for neuropathic pain and fibromyalgia in adults

Overview of attention for article published in Cochrane database of systematic reviews, May 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (92nd percentile)
  • High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

policy
1 policy source
twitter
18 tweeters
wikipedia
1 Wikipedia page

Citations

dimensions_citation
50 Dimensions

Readers on

mendeley
143 Mendeley
Title
Clonazepam for neuropathic pain and fibromyalgia in adults
Published in
Cochrane database of systematic reviews, May 2012
DOI 10.1002/14651858.cd009486.pub2
Pubmed ID
Authors

Ruth Corrigan, Sheena Derry, Philip J Wiffen, R Andrew Moore

Abstract

Antiepileptic drugs have been used in pain management since the 1960s; some have shown efficacy in treating different neuropathic pain conditions. Clonazepam, a benzodiazepine, is an established antiepileptic drug, but its place in the treatment of neuropathic pain is unclear.

Twitter Demographics

The data shown below were collected from the profiles of 18 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 143 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 1%
Germany 2 1%
Spain 1 <1%
Australia 1 <1%
Unknown 137 96%

Demographic breakdown

Readers by professional status Count As %
Student > Master 28 20%
Student > Bachelor 17 12%
Student > Postgraduate 15 10%
Researcher 14 10%
Student > Doctoral Student 11 8%
Other 31 22%
Unknown 27 19%
Readers by discipline Count As %
Medicine and Dentistry 70 49%
Nursing and Health Professions 14 10%
Neuroscience 7 5%
Psychology 5 3%
Pharmacology, Toxicology and Pharmaceutical Science 5 3%
Other 12 8%
Unknown 30 21%

Attention Score in Context

This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 April 2021.
All research outputs
#1,576,249
of 19,003,560 outputs
Outputs from Cochrane database of systematic reviews
#3,808
of 11,915 outputs
Outputs of similar age
#10,253
of 137,204 outputs
Outputs of similar age from Cochrane database of systematic reviews
#17
of 97 outputs
Altmetric has tracked 19,003,560 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,915 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 26.9. This one has gotten more attention than average, scoring higher than 68% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 137,204 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 97 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.